The chemistry is based on non-agonistic dectin-1 ligands and leads to a powerful vaccine adjuvant against infectious diseases such as influenza.
JST news release, February 12, 2013
National Institute of Biomedical Innovation develops CpG-based nanoparticle vaccine adjuvant showing fast reaction